Allograft-induced proliferation of vascular smooth muscle cells: potential targets for treating transplant vasculopathy
- PMID: 15320847
- DOI: 10.2174/1570161033386772
Allograft-induced proliferation of vascular smooth muscle cells: potential targets for treating transplant vasculopathy
Abstract
Despite advances in immunosuppressive drugs, coronary artery transplant vasculopathy (CATV) is the major cause of graft failure that limits long-term survival of cardiac transplantation. The pathogenesis of CATV involves a chronic immune response of the recipient to the donor vasculature in which activated recipient immune cells damage the endothelium and produce cytokines, resulting in vascular smooth muscle cell (VSMC) activation. Activated VSMC migrate from the media into the lumen, proliferate, and elaborate cytokines and matrix proteins, resulting in loss of lumen diameter and vascular contractility. Because of its extensive nature, interventions which are successful in patients with conventional coronary artery disease are often not applicable to the majority of patients with CATV. Although intended for immune suppression, many immunosuppressive agents owe at least part of their efficacy to their anti proliferative effects on VSMC, including rapamycin, mycophenolic acid, cyclosporin, calcium channel blockers, and HMG CoA reductase inhibitors. Because activation of VSMC is responsible for most of the obliterative arterial intimal thickening present in solid organ allografts, the induction of expression of a selected set of genes may reflect the status of acceptance of the vasculature by the recipient, and the activation, migration, and proliferation of VSMC represent potential points for therapeutic intervention. The risk of infection and malignancy associated with immunosuppressive therapy further promote the need to identify a molecular target which directly modulates the VSMC response to injury. This review will summarize the anti proliferative effects that immunosuppressive drugs have on VSMC proliferation. We will also describe efforts to define the genes which regulate the vascular response to allograft injury, and describe how some of these proteins may represent targets to reduce VSMC proliferation and attenuate CATV.
Similar articles
-
Antiproliferative effects of immunosuppressant drugs on vascular smooth muscle cells: an additional advantage for attenuating transplant vasculopathy.Drug News Perspect. 2004 Mar;17(2):110-6. doi: 10.1358/dnp.2004.17.2.829044. Drug News Perspect. 2004. PMID: 15098065 Review.
-
Epidermal growth factor receptor inhibition by erlotinib prevents vascular smooth muscle cell and monocyte-macrophage function in vitro.Transpl Immunol. 2015 Jun;32(3):175-8. doi: 10.1016/j.trim.2015.03.001. Epub 2015 Mar 17. Transpl Immunol. 2015. PMID: 25791345
-
Cardiac allograft vasculopathy: current review and future research directions.Cardiovasc Res. 2021 Nov 22;117(13):2624-2638. doi: 10.1093/cvr/cvab259. Cardiovasc Res. 2021. PMID: 34343276 Free PMC article. Review.
-
Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation.Circ Res. 2007 Sep 14;101(6):560-9. doi: 10.1161/CIRCRESAHA.107.151068. Epub 2007 Jul 26. Circ Res. 2007. PMID: 17656678
-
Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.Transplantation. 2004 Jun 15;77(11):1661-7. doi: 10.1097/01.tp.0000127592.13707.b6. Transplantation. 2004. PMID: 15201664
Cited by
-
HHEX: A Crosstalker between HCMV Infection and Proliferation of VSMCs.Front Cell Infect Microbiol. 2016 Nov 30;6:169. doi: 10.3389/fcimb.2016.00169. eCollection 2016. Front Cell Infect Microbiol. 2016. PMID: 27965937 Free PMC article.
-
AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic Allografts.Mol Ther Methods Clin Dev. 2019 Oct 2;15:246-256. doi: 10.1016/j.omtm.2019.09.009. eCollection 2019 Dec 13. Mol Ther Methods Clin Dev. 2019. PMID: 31720303 Free PMC article.
-
MicroRNA-30 inhibits neointimal hyperplasia by targeting Ca(2+)/calmodulin-dependent protein kinase IIδ (CaMKIIδ).Sci Rep. 2016 May 20;6:26166. doi: 10.1038/srep26166. Sci Rep. 2016. PMID: 27199283 Free PMC article.
-
A reproducible mouse model of chronic allograft nephropathy with vasculopathy.Kidney Int. 2012 Dec;82(11):1231-5. doi: 10.1038/ki.2012.277. Epub 2012 Aug 8. Kidney Int. 2012. PMID: 22874842 Free PMC article.
-
A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation.Transplantation. 2016 Nov;100(11):e106-e116. doi: 10.1097/TP.0000000000001407. Transplantation. 2016. PMID: 27495763 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources